发明授权
- 专利标题： Recombinant chemokine-antigen vaccine
- 专利标题（中）： 重组趋化因子 - 抗原疫苗
-
申请号： US11596100申请日： 2005-05-09
-
公开(公告)号： US08133873B2公开(公告)日： 2012-03-13
- 发明人: Shuren Zhang , Chen Lin , Wenxin Sun , Hanjun Qin , Chunxia Zhou , Xiao Liang , Dongmei Wang , Wenbo Ma , Xueyan Zhang , Ming Fu
- 申请人： Shuren Zhang , Chen Lin , Wenxin Sun , Hanjun Qin , Chunxia Zhou , Xiao Liang , Dongmei Wang , Wenbo Ma , Xueyan Zhang , Ming Fu
- 申请人地址： CN Beijing
- 专利权人： Cancer Institute, Chinese Academy of Medical Sciences
- 当前专利权人： Cancer Institute, Chinese Academy of Medical Sciences
- 当前专利权人地址： CN Beijing
- 代理机构： Cozen O'Connor
- 优先权： CN200410037910 20040510
- 国际申请： PCT/CN2005/000639 WO 20050509
- 国际公布： WO2005/108584 WO 20051117
- 主分类号： C07H21/04
- IPC分类号： C07H21/04 ; C07K14/00 ; C07K14/435 ; C07K16/46 ; A61K48/00
摘要：
A recombinant gene sequence that comprises human SLC gene, antigen gene, and IgG1-Fc fragment gene, wherein the SLC gene is linked upstream to the antigen gene, and the IgG1-Fc fragment is linked downstream to the antigen gene. This invention also relates to the application of the recombinant gene sequence in the preparation of gene vaccine.
公开/授权文献
- US20090209729A1 Recombinant chemokine-antigen vaccine 公开/授权日：2009-08-20